"Shares in drug developer Biotron have soared after data from a clinical trial of its lead anti-viral drug showed patients co-infected with HIV and hepatitis C were virus-free after six months of treatment."
Yes the markets should react further.
That statement however is fanciful.
They would have you believe that BOTH viruses have been controlled.
I'm quite disgusted that they can get away with this type of rubbish.
BIT Price at posting:
17.0¢ Sentiment: Buy Disclosure: Not Held
